Chronic Myeloid Leukemia: Symptoms and Treatments

Chronic Myeloid Leukemia (CML) is a type of cancer that originates in the bone marrow, where blood cells are produced. It primarily affects the white blood cells, leading to their uncontrolled growth.

This mutation results in the creation of an abnormal gene called BCR-ABL, which produces an enzyme that prompts the excessive growth of white blood cells.

While the exact cause of the genetic mutation is not well understood, several risk factors have been identified:

Age: CML is more common in older adults.
Gender: Males are slightly more likely to develop CML than females.
Radiation Exposure: High doses of radiation, such as those used in certain cancer treatments, have been linked to an increased risk of CML.

Symptoms of Chronic Myeloid Leukemia

CML often progresses slowly, and early stages may present with few or no symptoms. However, as the disease advances, symptoms become more apparent. Common symptoms include:

Fatigue: Persistent tiredness that doesn't improve with rest.
Weight Loss: Unintentional loss of weight.
Night Sweats: Excessive sweating during sleep.
Fever: Unexplained fevers without infection.
Fullness: A feeling of fullness or discomfort in the upper left abdomen due to an enlarged spleen.
Bone Pain: Pain or tenderness in bones and joints.
Bleeding: Easy bruising or bleeding.

Recognizing these symptoms early can facilitate timely diagnosis and treatment, potentially improving the prognosis.

Secure your health with a second opinion. Make informed decisions and book your appointment today!

Get A Second Opinion

How to Diagnose Chronic Myeloid Leukemia

Diagnosing CML involves a combination of physical examinations, blood tests, and bone marrow tests.

Physical Examination

A healthcare provider may start with a physical examination to check for signs of CML, such as an enlarged spleen or liver.

Blood Tests

Blood tests are essential for diagnosing CML. A complete blood count (CBC) can reveal abnormalities in the number and appearance of blood cells. Elevated white blood cell counts and the presence of immature cells called blasts are indicative of CML.

Bone Marrow Tests

Bone marrow aspiration and biopsy are crucial for confirming the diagnosis. These tests involve extracting a small sample of bone marrow, which is then examined for the presence of the Philadelphia chromosome and BCR-ABL gene.

Complications of Chronic Myeloid Leukemia

CML can lead to various complications, particularly if not treated effectively. Some of the potential complications include:

Blast Crisis

In advanced stages, CML can transform into a more aggressive form known as blast crisis, characterized by a rapid increase in immature white blood cells (blasts). This stage is similar to acute leukemia and is more challenging to treat.

Splenomegaly

An enlarged spleen (splenomegaly) can cause abdominal discomfort, pain, and a feeling of fullness. In severe cases, it may require surgical removal.

Infections

The abnormal white blood cells in CML can impair the immune system's ability to fight infections, making patients more susceptible to illnesses.

Anemia

CML can also affect the production of red blood cells, leading to anemia. Symptoms of anemia include fatigue, weakness, and shortness of breath.

Ready to take control of your health journey? Book your appointment now and start your path towards wellness today!

Book an Appointment

Chronic Myeloid Leukemia Prevention

While there is no surefire way to prevent CML, certain measures can reduce the risk of developing the disease. These include:

Avoiding Radiation Exposure: Limiting exposure to high doses of radiation, unless medically necessary, can reduce the risk.
Healthy Lifestyle: Maintaining a healthy lifestyle with a balanced diet, regular exercise, and avoiding smoking can support overall well-being and may reduce cancer risk.

Chronic Myeloid Leukemia Treatment

The treatment of CML has advanced significantly over the years, with targeted therapies playing a pivotal role. Treatment options include:

Tyrosine Kinase Inhibitors (TKIs)

TKIs are the cornerstone of CML treatment. These drugs specifically target the BCR-ABL enzyme, inhibiting its activity and preventing the uncontrolled growth of white blood cells. Common TKIs include:

Imatinib (Gleevec)
Dasatinib (Sprycel)
Nilotinib (Tasigna)

Chemotherapy

Chemotherapy may be used in cases where TKIs are ineffective or during a blast crisis. It involves using drugs to kill rapidly dividing cells, including cancer cells.

Stem Cell Transplant

For some patients, a stem cell transplant may be a viable option. This procedure involves replacing the diseased bone marrow with healthy stem cells from a donor. It carries significant risks but can offer a potential cure for CML.

Clinical Trials

Participation in clinical trials can provide access to new and potentially more effective treatments. Patients should discuss this option with their healthcare provider to determine if it is suitable for their condition.

Find Our Specialists